These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 12192882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of peripheral arterial diseases].
    Mikita J.
    Orv Hetil; 2005 May 29; 146(22):1209-11. PubMed ID: 15997667
    [No Abstract] [Full Text] [Related]

  • 4. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A.
    J Cardiovasc Pharmacol; 1990 May 29; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [Abstract] [Full Text] [Related]

  • 5. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A.
    Schweiz Med Wochenschr; 1988 Sep 10; 118(36):1283-9. PubMed ID: 3051339
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec 10; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 7. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr 10; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 8. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 10; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 10; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 10. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G, Tallarida G, Baldoni F, Raimondi G, Grimaldi I, Sangiorgi M.
    Clin Ter; 1985 Jul 15; 114(1):3-26. PubMed ID: 2864161
    [No Abstract] [Full Text] [Related]

  • 11. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR.
    Thromb Haemost; 2006 Jun 15; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract] [Full Text] [Related]

  • 12. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ, Safani M.
    Curr Med Res Opin; 2004 Nov 15; 20(11):1851-5. PubMed ID: 15537486
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic therapy in peripheral arterial occlusive disease.
    Clagett GP, Graor RA, Salzman EW.
    Chest; 1992 Oct 15; 102(4 Suppl):516S-528S. PubMed ID: 1395832
    [No Abstract] [Full Text] [Related]

  • 14. Medical treatment of peripheral arterial disease and claudication.
    Hiatt WR.
    N Engl J Med; 2001 May 24; 344(21):1608-21. PubMed ID: 11372014
    [No Abstract] [Full Text] [Related]

  • 15. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
    Violi F, Loffredo L, Annessi M.
    Ann Ital Med Int; 1999 May 24; 14(3):185-91. PubMed ID: 10566184
    [Abstract] [Full Text] [Related]

  • 16. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H.
    Hamostaseologie; 2006 Aug 24; 26(3):220-3. PubMed ID: 16906239
    [Abstract] [Full Text] [Related]

  • 17. Drug treatment of peripheral arterial disease in the elderly.
    Aronow WS.
    Drugs Aging; 2006 Aug 24; 23(1):1-12. PubMed ID: 16492065
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.
    Jaff MR.
    Angiology; 2002 Aug 24; 53(6):627-33. PubMed ID: 12463615
    [Abstract] [Full Text] [Related]

  • 19. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR, Clagett GP.
    Chest; 2001 Jan 24; 119(1 Suppl):283S-299S. PubMed ID: 11157655
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.